MedTech Europe IVDR Impact Report: The Good, The Bad And The Ugly

The outcome of a survey by trade association MedTech Europe shows that while more than 90% of companies benefited from the extension of IVDR transition deadlines, significant issues remain that could see many diagnostics disappear from the market.